Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective
Vandghanooni S, Eskandani M, Barar J, Omidi Y. J Mol Med (Berl). 2018 Jul 28. PubMed
Creation of unnatural base pairs for genetic alphabet expansion toward synthetic xenobiology
Hamashima K, Kimoto M, Hirao I. Curr Opin Chem Biol. 2018 Jul 27;46:108-114. PubMed
Interview with Jeroen Bremer, PhD
I became interested into the field of RNA-therapeutics during an internship at the department of Dermatology at the UMCG. Together with Peter van den
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
Javanbakht H, Mueller H, Walther J, Zhou X, Lopez A, Pattupara T, Blaising J, Pedersen L, Albæk N, Jackerott M, Shi T, Ploix C, Driessen W, Persson R, Ravn J, Young JAT, Ottosen S. Mol Ther Nucleic Acids. 2018 Jun 1;11:441-454. PubMed
Oligonucleotide therapy mitigates disease in Spinocerebellar Ataxia Type 3 mice
McLoughlin HS, Moore LR, Chopra R, Komlo R, McKenzie M, Blumenstein KG, Zhao H, Kordasiewicz HB, Shakkottai VG, Paulson HL. Ann Neurol. 2018 Jun 16. PubMed
CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis
Janzen E, Mendoza-Ferreira N, Hosseinibarkooie S, Schneider S, Hupperich K, Tschanz T, Grysko V, Riessland M, Hammerschmidt M, Rigo F, Bennett CF, Kye MJ, Torres-Benito L, Wirth B. Brain. 2018 Jun 28. PubMed
Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia
Terashima T, Ogawa N, Nakae Y, Sato T, Katagi M, Okano J, Maegawa H, Kojima H. Mol Ther Nucleic Acids. 2018 Jun 1;11:203-215. PubMed
Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma
Ligtenberg MA, Pico de Coaña Y, Shmushkovich T, Yoshimoto Y, Truxova I, Yang Y, Betancur-Boissel M, Eliseev AV, Wolfson AD, Kiessling R. Mol Ther. 2018 Jun 6;26(6):1482-1493. PubMed
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression
Zhang Y, Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y, Xiao L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish ...
Long non-coding RNA RAB11B-AS1 prevents osteosarcoma development and progression via its natural antisense transcript RAB11B
Chen Z, Liu Z, Yang Y, Zhu Z, Liang R, Huang B, Wu D, Yang L, Lu H, Jin D, Li Q. Oncotarget. 2018 Jun 1;9(42):26770-26786. PubMed
